Viatris | VTRS - Marktkapitalisierung

Aktienkurs
13.51
Täglich Wechseln
-0.29 -2.10%
Monatlich
-14.17%
Jährlich
48.46%
Q1 Prognose
13.10




Marktkapitalisierung Veränderung Datum
Cspc Pharmaceutical CNY 107.03B 26.09B 2025-09
Deva Holding AS TRY 17.54B 7.76B 2023-09
Dianthus Therapeutics USD 1.57B 967M 2025-09
Divis Laboratories Ltd INR 1.7T 186.62B 2025-12
Kangmei Pharma CNY 27.93B 1.73B 2025-09
Knight Therapeutics CAD 580.82M 31.21M 2025-06
Laboratorios Farma EUR 3.68B 430.05M 2026-01
Malin Corporation EUR 142.92M 19.65M 2026-02
Medical Developments International AUD 38.41M 24.12M 2026-03
Neuren Pharmaceuticals AUD 1.71B 645.78M 2026-03
Organigram Holdings CAD 378.8M 132.2M 2025-09
Ovoca Bio EUR 7.54M 4.28M 2022-06
Pharma Mar EUR 1.41B 63.87M 2026-03
Qiagen NV USD 9.9B 207.4M 2025-12
Sartorius EUR 16.41B 2.95B 2025-12
Sino Biopharmaceutical CNY 90.06B 33.55B 2025-06
Viatris USD 14.34B 2.8B 2025-12
Zealand Pharma A/S 33.35B 0 2026-02
Zz Pientze Pharmaceu CNY 118.73B 1.94B 2025-09